Effective treatment of vancomycin nephrotoxicity with continuous venous‐venous haemodiafiltration (CVVHDF) in a paediatric patient

Autor: Zutao Yu, Nan Chen, Yan Liu, Shuli Ma, Meng Lv
Rok vydání: 2020
Předmět:
Zdroj: Journal of Clinical Pharmacy and Therapeutics. 45:852-855
ISSN: 1365-2710
0269-4727
DOI: 10.1111/jcpt.13181
Popis: What is known and objective Vancomycin removal by dialysis uses methods that differ in type of dialysis membrane, dialysis fluxes and duration, ultrafiltration rate and Kt/Vurea (K = dialyser urea clearance, t = time on dialysis and V = total body water) in case of nephrotoxicity. We applied continuous venous-venous haemodiafiltration (CVVHDF) to treat a paediatric case of vancomycin nephrotoxicity caused by high serum trough concentrations. Case summary We report the case of a 4-year and 7-month-old boy with serum trough concentration of vancomycin of 86.0 mg/L after a 2-day treatment with vancomycin. His serum creatinine increased from 13.3 μmol/L at baseline to 227.0 μmol/L. We discontinued vancomycin and performed a 22-hours CVVHDF with high-flux membrane. Vancomycin decreased by 69.4% (82.1-25.1 mg/L), and renal function improved. What is new and conclusion Therapeutic drug monitoring and laboratory indicator measurements should be performed early during vancomycin treatment in paediatric patients with nephrotoxicity risk factors. Vancomycin removal by CVVHDF can be effective in paediatric acute kidney injury (AKI) associated with vancomycin-associated nephrotoxicity (VAN).
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje